Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osteogrow versus autologous iliac crest bone graft in adult single-level lumbar fusion
2017-000860-14Phase 2Completed
- Sponsor
- Genera Research Ltd.
- Start
- Jan 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, double-blind trial of bone morphogenetic protein 6 in degenerative disc disease (DDD) (3 arms), sponsored by Genera Research Ltd. Primary endpoints: Composite endpoint for safety and clinical success and Non-inferiority of patient success. Started Jan 2018; status: completed.
02
Drugs
bone morphogenetic protein 6
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on 2017-000860-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000860-14.